For 25 years, its hard-working, innovative and collaborative team has invented next-generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T-cell engagers, antibody-drug conjugates, next-generation immune checkpoint modulators and effector function-enhanced antibodies. Part of US Market Access, Strategic Pricing collaborates with colleagues across Market Access, Finance, Public Affairs & Policy, Global Market Access, and Legal to inform pricing decisions, develop payer and provider contracts, manage gross-to-net performance, and assess the business implications of federal and state policy developments.